Biotechne Corp (TECH)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

614 MCKINLEY PL N E MINNEAPOLIS, MN 55413

Techne and subsidiaries are engaged in the development, manufacture and sale of biotechnology products and hematology calibrators and controls. Co. has two segments: biotechnology and hematology. Co.'s biotechnology segment develops, manufactures and sells biotechnology research and diagnostic products. Co., through its biotechnology segment, supplies proteins such as cytokines and related reagents. Co. also produces and markets enzymes and intracellular signaling reagents. Co. also markets one type of immunoassay kit under the trade name Quantikine. Co.'s hematology segment develops and manufactures hematology controls and calibrators for both impedance and laser type cell counters.

Data as of 2020-05-30
Market Cap10.121 Billion Shares Outstanding38.223 Million Avg 30-day Volume338.232 Thousand
P/E Ratio54.6 Dividend Yield0.483 EPS4.73
Price/Sales13.414 Price cash flow ratio46.9 Price free cash flow ratio94.7
Book Value33.78 Price to Tangible Book281.36 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.391237
BETA1.13109 52-week High/Low282.52 / 155.17 Stddev0.077176

Are you looking for this stock instead?

View SEC Filings from TECH instead.

View recent insider trading info

Funds Holding TECH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TECH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

58.2 Thousand total shares from 18 transactions

Exercise Derivative Conversion (M)

82.7 Thousand total shares from 13 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EANSOR NORMAN DAVID PRESIDENT-PROTEIN SCIENCES

  • Officer
0 2020-05-28 6

FURLOW BRENDA S. SVP - GENERAL COUNSEL

  • Officer
4,311 2020-05-28 4

KUMMETH CHARLES R. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
138,330 2020-05-26 14

WIENS HAROLD J

4,843 2020-05-22 5

BAUMGARTNER ROBERT V

  • Director
9,221 2020-05-21 3

SETH ALPNA

  • Director
10,048 2020-05-15 1

KELDERMAN KIM PRES. DIAGNOSTICS & GENOM

  • Officer
1,668 2020-05-01 2

VESSEY RUPERT EVP, RESEARCH & EARLY DEV.

  • Officer
54,389 2020-05-01 3

HIGGINS JOHN L CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
205,173 2020-02-13 2

NUSSE ROELAND

  • Director
12,374 2019-11-25 2

HIPPEL JAMES CHIEF FINANCIAL OFFICER

  • Officer
9,307 2019-11-21 3

STEER RANDOLPH C

  • Director
4,721 2019-10-24 1

KEEGAN JOSEPH D

  • Director
1,748 2019-10-24 1

MELSEN GREGORY J

  • Director
0 2019-10-01 0

LUCAS ROGER C

  • Director
102,267 2019-03-05 0

DINARELLO CHARLES A

8,212 2018-08-08 0

BAZAN J. FERNANDO CHIEF TECHNICAL OFFICER

0 2017-10-26 0

GAVIN ROBERT M. SEN. VP PROTEIN PLATFORMS

1,667 2017-10-26 0

GOULD KEVIN S SVP CLINICAL CONTROLS

1,355 2017-10-26 0

HOLBROOK KAREN A

914 2017-09-06 0

VERONNEAU MARCEL SVP - CLINICAL CONTROLS

  • Officer
41,740 2015-08-07 0

OCONNELL HOWARD V

  • Director
72,000 2015-02-19 0

REAGAN KEVIN J SENIOR VP - BIOTECH

  • Officer
0 2014-12-05 0

OLAND THOMAS E CEO, PRESIDENT

  • Officer
  • Director
1,543,840 2011-11-30 0

HERBERT G A

  • Director
164,360 2008-10-23 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

WIENS HAROLD J

2020-05-29 M 3,985 d 0 4,843.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-29 S 709 $264.01 d 0 0.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-29 S 1,700 $260.83 d 6,209 0.00 direct

WIENS HAROLD J

2020-05-29 S 3,985 $260.00 d 4,843 4,843.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-29 M 7,909 d 0 0.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-29 S 2,100 $262.68 d 709 0.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-29 M 7,909 $108.49 a 7,909 0.00 direct

WIENS HAROLD J

2020-05-29 M 3,985 $101.19 a 8,828 4,843.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-29 S 3,400 $261.74 d 2,809 0.00 direct

FURLOW BRENDA S. - Officer SVP - GENERAL COUNSEL

2020-05-28 M 1,600 d 0 4,311.00 direct

FURLOW BRENDA S. - Officer SVP - GENERAL COUNSEL

2020-05-28 M 1,600 $94.35 a 10,306 4,311.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-28 M 3,448 $108.49 a 3,448 0.00 direct

FURLOW BRENDA S. - Officer SVP - GENERAL COUNSEL

2020-05-28 S 3,800 $260.38 d 4,311 4,311.00 direct

FURLOW BRENDA S. - Officer SVP - GENERAL COUNSEL

2020-05-28 M 5,995 $108.49 a 8,706 4,311.00 direct

FURLOW BRENDA S. - Officer SVP - GENERAL COUNSEL

2020-05-28 M 5,995 d 10,000 4,311.00 direct

FURLOW BRENDA S. - Officer SVP - GENERAL COUNSEL

2020-05-28 S 2,195 $259.72 d 8,111 4,311.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-28 M 3,448 d 7,909 0.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-28 S 3,448 $260.19 d 0 0.00 direct

KUMMETH CHARLES R. - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-26 F 13,018 $266.40 d 138,130 138,330.00 direct

KUMMETH CHARLES R. - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-26 M 21,159 $86.25 a 151,148 138,330.00 direct

KUMMETH CHARLES R. - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-26 M 21,159 d 25,157 138,330.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-22 M 3,963 d 0 0.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-22 S 7,676 $267.63 d 4,924 0.00 direct

WIENS HAROLD J

2020-05-22 G 378 d 4,843 4,843.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-22 M 8,637 $108.49 a 12,600 0.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-22 M 8,637 d 11,357 0.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-22 S 4,924 $268.41 d 0 0.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-22 M 3,963 $94.35 a 3,963 0.00 direct

BAUMGARTNER ROBERT V - Director

2020-05-21 S 125 $267.94 d 9,221 9,221.00 direct

BAUMGARTNER ROBERT V - Director

2020-05-21 S 1,300 $265.35 d 12,921 9,221.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-21 S 900 $268.89 d 0 0.00 direct

BAUMGARTNER ROBERT V - Director

2020-05-21 S 1,974 $267.32 d 9,346 9,221.00 direct

BAUMGARTNER ROBERT V - Director

2020-05-21 M 5,000 $70.35 a 14,221 9,221.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-21 M 11,037 d 3,963 0.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-21 S 10,137 $267.37 d 900 0.00 direct

BAUMGARTNER ROBERT V - Director

2020-05-21 M 5,000 d 0 9,221.00 direct

BAUMGARTNER ROBERT V - Director

2020-05-21 S 1,601 $266.07 d 11,320 9,221.00 direct

EANSOR NORMAN DAVID - Officer PRESIDENT-PROTEIN SCIENCES

2020-05-21 M 11,037 $94.35 a 11,037 0.00 direct

WIENS HAROLD J

2020-05-06 M 4,260 d 0 5,221.00 direct

WIENS HAROLD J

2020-05-06 S 4,260 $250.00 d 5,221 5,221.00 direct yes

WIENS HAROLD J

2020-05-06 M 4,260 $87.34 a 9,481 5,221.00 direct

KELDERMAN KIM - Officer PRES. DIAGNOSTICS & GENOM

2020-05-01 M 1,666 d 1,667 1,668.00 direct

KELDERMAN KIM - Officer PRES. DIAGNOSTICS & GENOM

2020-05-01 F 821 $227.54 d 1,668 1,668.00 direct

KELDERMAN KIM - Officer PRES. DIAGNOSTICS & GENOM

2020-05-01 M 1,666 a 2,489 1,668.00 direct

WIENS HAROLD J - Director

2020-04-30 M 4,000 $91.78 a 9,221 5,221.00 direct

WIENS HAROLD J - Director

2020-04-30 M 4,000 d 0 5,221.00 direct

WIENS HAROLD J - Director

2020-04-30 S 4,000 $225.00 d 5,221 5,221.00 direct yes

Elevate your investments